New booster shots designed to target the omicron variant and its subvariants, and the original strain of SARS-CoV-2, could become available in the U.S. in the coming weeks
Vaccine expert Ruth Karron discusses the authorization of COVID-19 vaccines for those under 5 years old, and what's likely to happen with the authorization over the next few weeks
Novavax uses a combination of spike proteins and an immune stimulant to provoke an immune response against the virus that causes COVID-19. Vaccine expert William Moss discusses its strengths and weaknesses ahead of its potential emergency use authorization.
Johns Hopkins health security expert Tom Inglesby provides an update on the state of the pandemic and how vaccination, funding, and variants may affect its future
Experts say the tragic milestone, now recorded by the Coronavirus Resource Center tracker, likely occurred months ago and that higher vaccination rates could have prevented many fatalities